Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
Leaving Website

You are now leaving and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

AARP to Congress: Do Something About Drug Prices

Organization’s volunteer president says seniors shouldn’t have to choose between medicine and food

spinner image A A R P National Volunteer President Catherine Alicia Georges talks at a hearing
Catherine Alicia Georges (center), AARP's national volunteer president, testifies at a hearing.

Older voters across the country want Congress to rein in the cost of prescription drugs so they don’t have to choose between paying for their medicines or going bankrupt, Catherine Alicia Georges, AARP’s national volunteer president and a longtime nurse, told a House of Representatives investigative committee on Tuesday.

“Current prescription price trends are simply not sustainable,’’ Georges told members of the House Oversight and Reform Committee, whose chairman, Rep. Elijah Cummings, D-Md., has launched an investigation into some of the nation’s highest-priced prescription drugs.

spinner image Image Alt Attribute

AARP Membership— $12 for your first year when you sign up for Automatic Renewal

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. Find out how much you could save in a year with a membership. Learn more.

Join Now

“Drug companies are working hard to try to shift the blame to others in the health care system, leaving them free to set incredibly high prices and increase them with little restraint.”

— Catherine Alicia Georges, AARP’s national volunteer president

Lawmakers from both chambers of Congress today began what is expected to be a series of hearings on how to curb the high prices of prescription drugs. At the Senate Finance Committee, Chairman Chuck Grassley, R-Iowa, said tackling high prescription drug costs will be one of the first priorities of his panel. At the Senate hearing, Grassley called for more transparency when it comes to drug prices. “You should not need a Ph.D. in economics,” he said, to be able to understand what prescription medicines cost.  Sen. Ron Wyden, D-Ore., said one of his priorities was for Medicare to use its bargaining power to “get a better deal” for seniors on drug prices, a key AARP priority.

House members also raised the issue of allowing Medicare to negotiate drug prices. “Why don’t we just let Medicare do for our senior citizens what the VA is doing for our veterans?” asked Rep. Stephen Lynch, D-Mass. Veterans pay a fixed $8 or $9 copay per prescription, Lynch said.

Georges told the House panel that in AARP’s 2018 voter issues survey, 92 percent of voters age 50 and older said that the candidates’ views on lowering drug costs were important to them, with 74 percent saying this issue was very important. Pre-election and exit polls consistently put health care access and cost as the most important issue for voters.

Georges also provided data to the committee illustrating the huge increases in prescription drug prices, particularly on brand name medicines. AARP Public Policy Institute’s most recent Rx Price Watch Report found that the retail prices of brand-name drugs widely used by older Americans increased by an average of 8.4 percent in 2017 — four times the rate of inflation. She also pointed out that the high cost of drugs “is passed along to everyone with health coverage through increased health care premiums, deductibles and other forms of cost sharing.” Georges also said that in 2015, seniors spent more than $27 billion out of pocket for their medicines.

See more Health & Wellness offers >

The high price of insulin – particularly for people who have Type 1 diabetes, was a focus of both congressional hearings.  Antroinette  Worsham had two children with Type 1 diabetes. She told the House panel that her older daughter, Antavia, died at age 22 after she began rationing her insulin at 21 when she was no longer eligible for an Ohio program that helps children with medical handicaps. “I fear the same thing will happen to  Antanique  when she turns 21,” Worsham said of her younger daughter, a freshman at the University of Toledo. “How do pharmaceutical [companies] think college students are supposed to be able to pay for high drug costs on top of high tuition and room and board?” Another mother of a young man at DePauw University told senators that her son began rationing his insulin when he found out what the medicine cost. Grassley said he plans to “get to the bottom of the insulin price increase.”

Discover AARP Members Only Access

Join AARP to Continue

Already a Member?